Skip to main content

Table 2 Effects of MCC950 treatment in adenine-induced chronic renal failure (CRF) on the percentage expression of interleukin-1 beta (IL-1β) and caspase-3 in the kidney of rats

From: Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive

Group Immune stain

Control -ve

Adenine-induced CRF group

MCC950 treated group

IL-1beta

14.52a

49.75b

22.74a

Caspase-3

11.05a

44.06b

18.50a

  1. a,b values are not sharing a common superscript letter differ significantly at P < 0.05